- Name:Cancer Immunotherapy
- Class：Cancer Immunotherapy
We have proved that when our TLR-7 agonists were conjugated to tumor specific (associate) antigen, they could activate and guide the immune system to mount attack on tumor cell.
It is perticularly useful in eradicating small cluster or circulating tumor cells.
For more details on Cancer Vaccine, please see:
Nat Rev Clin Oncol 11, 509 (2014)